APA (7th ed.) Citation

Faivre, L., Crépin, J., Réda, M., Nambot, S., Carmignac, V., Abadie, C., . . . Vabres, P. (2023). Low risk of embryonic and other cancers in PIK3CA‐related overgrowth spectrum: Impact on screening recommendations. Clinical genetics, 104(5), 554-563. https://doi.org/10.1111/cge.14410

Chicago Style (17th ed.) Citation

Faivre, Laurence, et al. "Low Risk of Embryonic and Other Cancers in PIK3CA‐related Overgrowth Spectrum: Impact on Screening Recommendations." Clinical Genetics 104, no. 5 (2023): 554-563. https://doi.org/10.1111/cge.14410.

MLA (9th ed.) Citation

Faivre, Laurence, et al. "Low Risk of Embryonic and Other Cancers in PIK3CA‐related Overgrowth Spectrum: Impact on Screening Recommendations." Clinical Genetics, vol. 104, no. 5, 2023, pp. 554-563, https://doi.org/10.1111/cge.14410.